Cooper Laurence James Neil 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Award
Common Stock
2017-12-29+348,000→ 1,431,731 total - Tax Payment
Common Stock
2017-12-31$4.14/sh−16,157$66,890→ 1,389,396 total - Tax Payment
Common Stock
2017-12-30$4.14/sh−26,178$108,377→ 1,405,553 total
Footnotes (2)
- [F1]116,000 shares shall vest on each of 12/29/2018, 12/29/2019 and 12/29/2020.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.